• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Pipeline

Pipeline

August 23, 2021
Company Drug/Device Medical Condition Status
Novatek Pharmaceuticals TQ Formula oral treatment for COVID-19 patients in an outpatient setting IND approved by the FDA
Occlutech Flex II PFO occluder patients with cryptogenic stroke Investigational Device Exemption approved by the FDA
Angel Pharmaceuticals CPI-818 relapsed/refractory T-cell lymphomas IND approved by the China National Medical Products Administration
Enlivex Therapeutics Allocetra treatment of patients with severe and critical COVID-19 experiencing acute respiratory distressed syndrome authorization granted by the Israeli Ministry of Health for a phase 2b trial
Istari Oncology PVSRIPO head and neck squamous-cell carcinoma initiation of phase 1/2 substudy
Turning Point Therapeutics repotrectinib in combination with trametinib RAS G12D-mutated advanced solid tumors initiation of phase 1b/2 trial
Trigone Pharma TRG-100 interstitial cystitis/ bladder pain syndrome initiation of phase 2 trial
Cali Biosciences CPL-01 (extended-release injectable ropivacaine hydrochloride) long-acting postoperative analgesic initiation of phase 2b trial
Pfizer-BioNTech COVID-19 Vaccine COVID-19 Emergency Use Authorization (EUA) amended to include an additional shot in certain immunocompromised people
Moderna COVID-19 Vaccine COVID-19 EUA amended to include an additional shot in certain immunocompromised people
Spectrum Solutions SDNA-1000 saliva collection device at-home COVID-19 testing EUA amended to include the unsupervised self-collection of saliva
Eli Lilly Lyumjev (insulin lispro-aabc injection) subcutaneous pump glycemic control in adults with type 1 and type 2 diabetes approved by the FDA for expanded administration
GlaxoSmithKline Jemperli (dostarlimab) adults with dMMR recurrent or advanced solid tumors approved by the FDA for expanded indication
Jazz Pharmaceuticals Xywav (calcium, magnesium, potassium and sodium oxybates) oral solution idiopathic hypersomnia approved by the FDA for new indication
Merck Welireg (belzutifan) treatment of adult patients with certain types of Von Hippel-Lindau disease-associated tumors approved by the FDA
Pfizer Ticovac tick-borne encephalitis (TBE) vaccine active immunization to prevent TBE in individuals age one year and older approved by the FDA
GC Pharma GreenGene F (beroctocog alfa) recombinant human coagulation factor VIII for injection control and prophylaxis of bleeding episodes in patients with hemophilia A approved in China
Nasus Pharma Taffix intranasal powder viral infections approved in Spain
Photocure Hexvix (hexaminolevulinate HCl) management of bladder cancer approved in Chile

 

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing